Key Takeaways
Shares of Aehr Test Systems (NASDAQ: AEHR) have climbed more than 350% in 2026, with the semiconductor testing firm's valuation pushed higher by a record $41 million order from a leading, unnamed AI hyperscaler customer.
The sharp increase in share price comes as analysts revise their outlooks, with Lake Street maintaining a Buy rating and raising its price target to $56, citing the robust bookings momentum. Freedom Broker also increased its target to $61 but kept a Hold rating on the stock.
The order, the largest in Aehr’s history, is for its Sonoma high-power package-level test and burn-in systems for custom AI processor ASICs, with deliveries set to begin in fiscal 2027. The deal contributed to record quarterly bookings of $37.2 million and an effective backlog of over $50 million. This strong forward-looking demand contrasts with the company's mixed Q3 2026 results, where it posted a revenue of $10.3 million, missing forecasts of $10.8 million, though its earnings per share of -$0.05 beat expectations.
The record order provides a significant validation of Aehr's technology for the high-growth AI chip market, but the company's path forward includes navigating execution risks and recent shareholder dilution. The company completed a $60 million at-the-market equity offering on April 17. The move bolsters its balance sheet but comes as two directors, Fariba Danesh and Rhea J. Posedel, collectively sold more than $1.3 million in stock in the same week, capitalizing on a 937% gain over the past year.
The surge in Aehr Test Systems' stock price has made it one of the top performers in the U.S. market this year. The company, which specializes in test and burn-in systems for semiconductor devices, is benefiting from the explosive growth in demand for AI processors. The record $41 million order from a hyperscale customer underscores the critical need for high-reliability testing solutions for complex AI chips.
While the market has reacted positively to the company's growth prospects, some data points suggest caution. The stock is currently trading near its 52-week high of $91.43, and analysis from InvestingPro suggests it appears overvalued. The company has not been profitable over the last twelve months, posting a negative EPS of $0.38.
The recent insider sales by two directors, though a small fraction of their total holdings, could be interpreted by some investors as a sign that those with the most intimate knowledge of the business are taking profits after a significant run-up. The completion of the $60 million equity offering provides the company with capital for growth and operations but also dilutes existing shareholders.
Broader market conditions were positive, with the Nasdaq Composite gaining 1.2% and the S&P 500 rising 0.8% on the day of the insider sale report. In commodity markets, Brent crude futures traded above $100 a barrel, reflecting ongoing geopolitical tensions.
This article is for informational purposes only and does not constitute investment advice.
